The novel vaccine delivery device market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

iCrowdNewswire

May 20, 2021

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”.

The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:

A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.
A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.
An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.
A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.
Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).
An analysis of the partnerships that have been established in this domain, in the recent past.
A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Global Novel Vaccine Delivery Devices (By Value)

Type of Device
- Electroporation-based Needle Free Injection Systems
- Oral Delivery Systems
- Nasal Delivery Systems
- Jet Injectors
- Microneedle Patches
- Microinjectors

Route of Administration
- Oral
- Intramuscular
- Intranasal
- Intradermal
- Subcutaneous

Type of Vaccines
- Bivalent Oral Polio Vaccine
- BCG Vaccine
- DTP-HepB-Hib Vaccine
- Pneumococcal Conjugate Vaccine
- Influenza Vaccine
- Measles Vaccine
- Tetanus-Diphtheria Vaccine
- Others

Key Geographical Region

North America
Europe
Asia Pacific
Rest of the World

Key companies covered in the report

3M
Becton Dickinson
Consort Medical
D’Antonio Consultants International
Enesi Pharma
Ichor Medical
Iconovo
Inovio Pharmaceuticals
PharmaJet
Union Medico

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030
Large Volume Wearable Injectors Market (4th Edition), 2018-2030
Global Autoinjectors Market (2nd Edition), 2018-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information:

Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis